HDAC1 and ovarian carcinoma: Recently, Lv et al. [115] showed that the overexpression of HDAC1 decreased cisplatin sensitivity, promoted proliferation and blocked the suppressive effects of miR-34a on cell proliferation in ovarian cancer cells.